CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23
S. Gruschow, S. McQuarrie, K. Ackermann, S. McMahon, B. Bode, T. M. Gloster, M. F. White
This study identifies Csx23 as a CRISPR effector that uses cyclic nucleotide binding to mediate antiphage defence in Vibrio cholerae.
bioRxiv · Nov 24, 2023Microbiology